Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
2018; American Association for the Advancement of Science; Volume: 10; Issue: 467 Linguagem: Inglês
10.1126/scitranslmed.aat5933
ISSN1946-6242
AutoresClaudio Scafoglio, Brendon Villegas, Gihad Abdelhady, Sean T. Bailey, Jie Liu, Aditya S. Shirali, W. Dean Wallace, Clara E. Magyar, Tristan Grogan, David Elashoff, Tonya C. Walser, Jane Yanagawa, Denise R. Aberle, Jorge R. Barrio, Steven M. Dubinett, David B. Shackelford,
Tópico(s)Neuroendocrine Tumor Research Advances
ResumoLung premalignancy and early-stage adenocarcinoma use a mechanism of glucose transport that can be targeted for early diagnosis and treatment.
Referência(s)